Table 2—

Exhaled nitric oxide(NO) levels from systemic sclerosis (SSc) patients with and without interstitial lung disease (ILD)

SScp-value
With ILDWithout ILD
Subjects n3325
Age yrs55.8 (47.3–60.8)52.4 (44.7–59.0)ns
Smoker n46ns
Jaw,NO nL·min−14.1 (-18.9–13.6)18.0 (-0.2–39.6)<0.05
CA,NO ppb7.5 (5.2–11.9)4.9 (3.1–7.0)<0.01
R20.96 (0.92–0.98)0, 95 (0.93–0.98)ns
FeNO50 ppb9.3 (5.8–17.1)11.1 (6.1–19.0)ns
TLC % pred82 (68–95)105 (90–107)<0.001
FVC % pred81 (70–97)97 (83–115)<0.01
FEV1 % pred83 (74–100)92 (83–105)ns
Pa,O2 mmHg84 (79–98)86 (82–97)ns
DL,CO % pred53 (42–66)65 (59–82)<0.01
DL,CO/AV % pred73 (58–82.7)76 (71–85)ns
Ground-glass score#8 (6–12)0 (0–0)<0.001
Reticular score#7 (4–9)0 (0–0)<0.001
  • Data are presented as median (1st–3rd quartile), unless otherwise stated. R2: relationship between the elimination rate of NO and exhalation flow rate; FeNO50: fractional exhaled NO concentrationat 50 mL·s−1 constant flow rate; TLC: total lung capacity; % pred: % predicted; FVC: forced vital capacity; FEV1: forced expiratory volume in one second; Pa,O2: arterial oxygen tension; DL,CO: diffusing capacity of the lung for carbon monoxide; AV: alveolar volume; ns: nonsignificant #: maximum of each score is 25. 1 mmHg = 0.133 kPa.